10-Q: AquaBounty Technologies Reports Significant Losses and Asset Impairments in Q3 2024

AquaBounty Technologies reported a substantial net loss of $65.1 million for the nine months ended September 30, 2024, primarily due to significant asset impairments and reduced product revenue.

Summary

• AquaBounty Technologies reported a net loss of $3.4 million for the three months ended September 30, 2024, and a net loss of $65.1 million for the nine months ended September 30, 2024.
• The company experienced a significant decrease in product revenue, primarily due to the sale of its Indiana farm, which impacted sales of GE Atlantic salmon.
• The company recorded a $48.7 million non-cash impairment charge against long-lived assets, primarily related to the Indiana and Ohio farms.
• AquaBounty's cash and cash equivalents stood at $500 thousand as of September 30, 2024, raising substantial doubt about its ability to continue as a going concern.
• The company is actively pursuing various funding and strategic alternatives, including the sale of its Rollo Bay farm and additional equipment from the Ohio farm.
• The company's total revenue for the nine months ended September 30, 2024 was $705,262, compared to $1,919,409 for the same period in 2023.

Sentiment

Score: 2

Explanation: The document paints a very negative picture of the company's financial health, with significant losses, asset impairments, and a critical cash position. The company's ability to continue as a going concern is in doubt, and the need for a capital raise is urgent. The sentiment is overwhelmingly negative from an investment perspective.

Positives

• The company received $9.0 million from the sale of its Indiana farm in July 2024 and an additional $500 thousand in October 2024.
• The company is actively pursuing various funding and strategic alternatives to improve its financial position.
• Sales and marketing expenses decreased due to cost-cutting measures.
• Research and development expenses decreased due to cost-cutting measures.
• General and administrative expenses decreased due to cost-cutting measures.

Negatives

• The company has a history of net losses and expects this to continue.
• The company's cash position is critically low at $500 thousand.
• The company recorded a significant $48.7 million non-cash impairment charge.
• Product revenue decreased significantly due to the sale of the Indiana farm.
• The company's ability to continue as a going concern is in doubt.
• The company has paused construction activities at its Ohio farm.

Risks

• The company's ability to raise additional capital is uncertain.
• The company may not be able to sell its Rollo Bay farm or additional equipment from the Ohio farm on acceptable terms.
• The company is subject to risks common in the biotechnology and aquaculture industries.
• The company faces risks related to the commercial acceptance of its genetically engineered salmon.
• The company is exposed to risks related to disease outbreaks and fish mortality events.
• The company is subject to risks related to inflation and increasing operating costs.

Future Outlook

The company expects its future capital requirements to be substantial and is pursuing various funding and strategic alternatives to improve its financial position. The company's ability to continue as a going concern is dependent on its ability to raise additional capital.

Management Comments

• The company is pursuing a range of funding and strategic alternatives, including the completed sale of our Indiana farm.
• We continue to pursue funding sources, including our decision to sell our Rollo Bay farm, the sale of non-core equipment assets from our Ohio farm, debt financing secured by our unencumbered assets, and potential strategic transactions.
• We expect inflation to continue to negatively impact our results of operations for the near-term.

Industry Context

The company operates in the land-based aquaculture industry, which is facing challenges related to high operating costs and the need for significant capital investment. The company's struggles highlight the difficulties in scaling up production of genetically engineered salmon and achieving profitability in this sector.

Comparison to Industry Standards

• Compared to other aquaculture companies, AquaBounty's financial performance is significantly weaker, with substantial losses and a critical cash position.
• Other companies in the sector, such as Atlantic Sapphire, have also faced challenges in scaling up production and achieving profitability, but AquaBounty's situation appears more precarious.
• The company's asset impairments are unusually high, indicating significant challenges in its business model and asset valuations.
• The company's reliance on asset sales to generate liquidity is not a sustainable long-term strategy, and it is not common for companies in the sector to be in such a position.

Stakeholder Impact

• Shareholders are at risk of losing most or all of their investment if the company cannot continue as a going concern.
• Employees may be affected by potential cost-cutting measures or restructuring.
• Customers may be impacted by the company's reduced production capacity and potential changes in product availability.
• Suppliers may face uncertainty regarding future orders and payments.
• Creditors face increased risk of non-payment due to the company's financial difficulties.

Next Steps

• The company plans to sell its Rollo Bay farm and additional equipment assets from its Ohio farm to increase cash liquidity.
• The company will continue to pursue various funding and strategic alternatives.
• The company will need to secure additional financing to fund its operations and execute its business plan.

Key Dates

Keywords

AquaBounty, genetically engineered salmon, aquaculture, financial results, asset impairment, going concern, capital raise, farm sale, net loss, liquidity